Full Episode
Friday, Sep 5
PBS NewsHour
  • Episodes
  • Podcasts
  • Newsletters
  • The Latest
  • Politics
    Politics
    • Brooks and Capehart
    • Politics Monday
    • Supreme Court
  • Arts
    Arts
    • CANVAS
    • Poetry
    • Now Read This
  • Nation
    Nation
    • Supreme Court
    • Race Matters
    • Essays
    • Brief But Spectacular
  • World
    World
    • Agents for Change
  • Economy
    Economy
    • Making Sen$e
    • Paul Solman
  • Science
    Science
    • The Leading Edge
    • ScienceScope
    • Basic Research
    • Innovation and Invention
  • Health
    Health
    • Long-Term Care
  • Education
    Education
    • Teachers' Lounge
    • Student Reporting Labs
  • For Teachers
    Education
    • Newshour Classroom
  • About
    • Feedback
    • Funders
    • Support
    • Jobs

We're not going anywhere.

Stand up for truly independent, trusted news that you can count on!
Donate now
PBS News

Get news alerts from PBS News

Turn on desktop notifications?

pfizer

  • Full Episodes
  • Podcasts
  • Newsletters
  • Live

Dec 16

CDC panel recommends Pfizer, Moderna vaccines over Johnson & Johnson shot due to blood clot risk

By Lauran Neergaard, Mike Stobbe, Associated Press

Thursday's recommendation came after government advisers reviewed new safety data about rare but potentially life-threatening blood clots linked to J&J's shot.

Continue reading

Dec 14

Pfizer confirms COVID pill’s results, effectiveness against omicron

By Matthew Perrone, Associated Press

The company also confirmed Tuesday that the pill delivered on promising early results in reducing COVID-19 hospitalizations and deaths.

Continue reading

Dec 09

FDA expands Pfizer COVID booster, opens extra dose to age 16

By Lauren Neergaard and Matthew Perrone, Associated Press

The U.S. and many other nations already urge adults to get a booster to pump up their immunity months after initial vaccination.

Continue reading

Dec 08

Pfizer says COVID booster offers protection against omicron variant

By Lauran Neergaard, Associated Press

Pfizer and its partner BioNTech said lab tests showed a booster dose increased by 25-fold the level of so-called neutralizing antibodies against omicron.

Continue reading

Nov 19

FDA expands COVID boosters to all adults, final hurdle ahead

By Lauren Neergaard and Matthew Perrone, Associated Press

If the Centers for Disease Control and Prevention agrees, tens of millions more Americans could have three doses of protection ahead of the new year. Anyone who got the one-dose Johnson & Johnson vaccine can already get a booster.

Continue reading

Nov 17

Watch 5:48
How the COVAX vaccine program is faring, and what challenges developing nations still face

By William Brangham, Karina Cuevas

The Biden administration is ramping up plans for vaccine manufacturing for the coming year. But developing nations have been struggling with delays and short supplies for months and will not meet their vaccination goals for this year. Drug maker Moderna…

Continue watching

Nov 16

Pfizer asks U.S. regulators to approve promising COVID pill

By Matthew Perrone, Associated Press

Pfizer is submitting its experimental pill for COVID-19 for U.S. authorization, setting the stage for a likely launch of the promising therapy in coming weeks.

Continue reading

Nov 09

FDA to consider COVID-19 booster shots from Pfizer for all adults

By Lauran Neergaard, Associated Press

Pfizer is asking U.S. regulators to allow boosters of its COVID-19 vaccine for anyone 18 or older. Older Americans and other groups particularly vulnerable to the virus have had access to a third dose of the Pfizer and BioNTech vaccine…

Continue reading

Nov 05

Watch 4:45
News Wrap: Pfizer says its COVID-19 pill cuts hospitalization, death risk by 90%

In our news wrap Friday, Pfizer announced strong results for a pill to treat COVID-19. Trials show it cuts infections and deaths by nearly 90 percent in high-risk adults. Three white men accused of murdering Ahmaud Arbery, a Black man,…

Continue watching

Nov 05

Pfizer says COVID-19 pill cut hospital, death risk by 90 percent

By Matthew Perrone, Associated Press

Since the beginning of the pandemic last year, researchers worldwide have been racing to find a pill to treat COVID-19 that can be taken at home to ease symptoms, speed recovery and keep people out of the hospital.

Continue reading

Jump to the First Page Previous Page
1 2 3 4 5 6 7 8 9 13
Next Page Jump to the Last Page

Support Provided By: Learn more

web ad

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Full Episode
Friday, Sep 5
  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You
  • Friends of the News Hour
PBS News

© 1996 - 2025 NewsHour Productions LLC. All Rights Reserved.

PBS is a 501(c)(3) not-for-profit organization.

Sections

  • The Latest
  • Politics
  • Arts
  • Nation
  • World
  • Economy
  • Science
  • Health
  • Education

About

  • About Us
  • TV Schedule
  • Press
  • Feedback
  • Funders
  • Support
  • Newsletters
  • Podcasts
  • Jobs
  • Privacy
  • Terms of Use

Stay Connected

  • Facebook
  • YouTube
  • Instagram
  • X
  • TikTok
  • Threads
  • RSS

Subscribe to Here's the Deal with Lisa Desjardins

Form error message goes here.

Thank you. Please check your inbox to confirm.

Support our journalism

Support for News Hour Provided By

  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You